ICU Medical, Inc. Reports Fourth Quarter and Year-End 2006 Results
- Company Revenue for 2006 Increased 28% to a New Record -
SAN CLEMENTE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- ICU Medical,
Inc., (Nasdaq: ICUI), a leading low cost manufacturer of safe medical
connectors, custom medical products and critical care devices, today
announced results for the fourth quarter and year ended December 31, 2006.
Fourth quarter revenue was $52.8 million, a 22% increase as compared to
$43.2 million in the same period last year. Net income increased 29% to
$6.9 million, or $0.44 per diluted share, as compared to a net income of
$5.3 million, or $0.35 per share, in the fourth quarter of 2005.
For the year ended December 31, 2006, the Company earned $25.7 million,
or $1.64 per share, on revenues of $201.6 million, as compared to net
income of $20.3 million, or $1.35 per share, on revenues of $157.5 million
for the year ended December 31, 2005.
"We are pleased with the strong revenue growth in many of our lines
during 2006, especially our custom medical products. Revenue for the fourth
quarter and for the year are both record highs for the Company," said Frank
O'Brien, ICU Medical's Chief Financial Officer. "We attribute our continued
success to the market acceptance of our leading line of product offerings."
ICU continued to strengthen its balance sheet and operating cash flow
in 2006. Operating cash flows were $31.6 million for the year. At year-end
2006, cash and investments totaled $116.9 million and working capital rose
$30.6 million to $154.5 million from $123.9 million at December 31, 2005.
In addition, the Company bought back $8.0 million of shares in the open
market during 2006 and early 2007.
Mr. O'Brien concluded, "We will continue to re-invest our free cash
flow from core product lines into developing new products, improving
manufacturing efficiencies, strategic investments and acquisitions and
continued purchases of our shares. We have just decided to increase our
share purchase program to $20 million."
The foregoing statement concerning Management's expectation with
respect to future results is a forward looking statement based upon the
best information currently available to Management and assumptions
Management believes are reasonable, but Management does not intend the
statement to be a representation as to future results. Future results are
subject to risks and uncertainties, including the most recent 10-Q. Actual
results in the future may differ materially from Management's current
expectations.
Contact: Francis J. O'Brien
Chief Financial Officer
ICU Medical, Inc.
(949) 366-2183
John F. Mills
Senior Managing Director
Integrated Corporate Relations
(310) 954-1100
ICU Medical, Inc.
Summary Consolidated Statements of Income
(all amounts in thousands except share and per share data)
Quarter ended Year ended
December 31, December 31,
2006 2005 2006 2005
(unaudited) (unaudited) (unaudited) (1)
TOTAL REVENUE 52,807 43,230 201,613 157,532
COST OF GOODS SOLD 35,397 24,660 120,929 88,128
OPERATING EXPENSES 12,472 11,514 49,811 41,809
Income from operations 4,938 7,056 30,873 27,595
OTHER 1,373 753 5,027 3,138
BENEFIT (PROVISION) FOR
INCOME TAXES 549 (2,498) (10,240) (10,459)
NET INCOME $6,860 $5,311 $25,660 $20,274
NET INCOME PER SHARE
Diluted $0.44 $0.35 $1.64 $1.35
WEIGHTED AVERAGE NUMBER OF
SHARES
Diluted 15,745,716 15,216,973 15,599,132 15,039,890
(1) 2005 amounts were derived from the audited consolidated financial
statements of ICU Medical, Inc.
ICU Medical, Inc.
Summary Consolidated Balance Sheet Data
(all amounts in thousands except share data)
ASSETS
12/31/06 12/31/05
(unaudited) (1)
CURRENT ASSETS:
Cash and liquid investments $116,918 $86,742
Accounts receivable, net 26,533 23,644
Inventories 16,315 15,435
Prepaid and deferred income taxes 6,915 7,241
Other current assets 4,255 4,700
Total current assets 170,936 137,762
PROPERTY AND EQUIPMENT, NET 59,037 52,194
DEFERRED INCOME TAXES 5,340 723
OTHER ASSETS 10,895 13,858
$246,208 $204,537
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES $16,451 $13,887
DEFERRED INCOME TAXES - long-term
portion 4,512 529
MINORITY INTEREST 358 923
STOCKHOLDERS' EQUITY:
14,620,421 common shares
outstanding at December 31, 2006 224,887 189,198
$246,208 $204,537
(1) December 31, 2005 amounts were derived from the audited consolidated
financial statements of ICU Medical, Inc.
ICU Medical, Inc.
Summary Consolidated Statements of Cash Flows
(all amounts in thousands)
Year ended
12/31/06 12/31/05
(unaudited) (1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income $25,660 $20,274
Adjustments to reconcile net income to
net cash
provided by operating activities --
Depreciation and amortization 11,231 9,698
Net change in current assets and
liabilities, and other (5,283) (6,938)
Tax benefits from exercise of
stock options in 2005 -- 4,338
Net cash provided by operating
activities 31,608 27,372
CASH PAID FOR ACQUIRED ASSETS -- (32,606)
PURCHASES OF PROPERTY AND EQUIPMENT (19,612) (5,509)
PROCEEDS FROM SALE OF BUILDING 6,062 --
NET CHANGE IN LIQUID INVESTMENTS (23,877) 1,837
EMPLOYEE EQUITY PLANS 16,261 7,657
OTHER (4,143) 2,487
NET INCREASE IN CASH AND CASH
EQUIVALENTS $6,299 $1,238
(1) 2005 amounts were derived from the audited consolidated financial
statements of ICU Medical, Inc.
SOURCE ICU Medical, Inc.
More by this Source
ICU Medical Announces European Launch of the New Diana™ Automated Hazardous Drug Compounding System
Mar 12, 2013, 08:00 ET
New U.S. Market Data Shows ICU Medical's Needlefree IV Connector Technology Chosen More than Twice as Often as Any Other
Mar 07, 2013, 08:00 ET
ICU Medical's Neutron™ Needlefree Catheter Patency Device May Help Healthcare Facilities Deal With Cathflo® Shortages by Significantly Reducing Catheter Occlusions
Mar 04, 2013, 08:00 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




